Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Møller

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Blood|April 9, 2008
First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trialAnton Hagenbeek, Ole Gadeberg, Peter Johnson, et al.
Blood Advances|November 21, 2024
Incidence and characterization of secondary CNS lymphoma in 1972 patients with DLBCL: a Danish nationwide cohort studyElisabeth Reuben Tolley, Torsten Holm Nielsen, Ditte Stampe Hersby, et al.
Trials|July 19, 2012
The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trialAnne Juul Wikkelsoe, Arash Afshari, Jakob Stensballe, et al.
European Journal of Haematology|January 9, 2025
Impact of Trial Eligibility Criteria on Outcomes of 1183 Patients With Follicular Lymphoma Treated in the Real-World SettingTine Litske Bennedsen, Mikkel Runason Simonsen, Paw Jensen, et al.
Blood Cancer Journal|September 30, 2024
Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohortMarie Hairing Enemark, Jonas Klejs Hemmingsen, Maja Dam Andersen, et al.
Frontiers in Oncology|December 9, 2022
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHVUffe Klausen, Jacob Handlos Grauslund, Nicolai Grønne Dahlager Jørgensen, et al.
Oncoimmunology|January 29, 2024
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphomaUffe Klausen, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund, et al.
BMC Medicine|September 29, 2017
Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European UnionJürgen Rehm, Peter Anderson, Jose Angel Arbesu Prieto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2021
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Blood|April 9, 2008
First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trialAnton Hagenbeek, Ole Gadeberg, Peter Johnson, et al.
Blood Advances|November 21, 2024
Incidence and characterization of secondary CNS lymphoma in 1972 patients with DLBCL: a Danish nationwide cohort studyElisabeth Reuben Tolley, Torsten Holm Nielsen, Ditte Stampe Hersby, et al.
Trials|July 19, 2012
The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trialAnne Juul Wikkelsoe, Arash Afshari, Jakob Stensballe, et al.
European Journal of Haematology|January 9, 2025
Impact of Trial Eligibility Criteria on Outcomes of 1183 Patients With Follicular Lymphoma Treated in the Real-World SettingTine Litske Bennedsen, Mikkel Runason Simonsen, Paw Jensen, et al.
Blood Cancer Journal|September 30, 2024
Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohortMarie Hairing Enemark, Jonas Klejs Hemmingsen, Maja Dam Andersen, et al.
Frontiers in Oncology|December 9, 2022
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHVUffe Klausen, Jacob Handlos Grauslund, Nicolai Grønne Dahlager Jørgensen, et al.
Oncoimmunology|January 29, 2024
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphomaUffe Klausen, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund, et al.
BMC Medicine|September 29, 2017
Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European UnionJürgen Rehm, Peter Anderson, Jose Angel Arbesu Prieto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2021
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
Pageof 6